Health care technology firm Mayo Clinic raised $30 million in a series C round funding led by Qiming Venture Capital and followed by WuXi Apptec and Huimei Capital. Use of investment is not disclosed.
Mayo Clinic’s main business R&D of CDSS and the application of its products in major 3 A companies and local clinics through AI assisted clinical treatment.
South Africa Today